Evidence map›Paper›PMID 35118032›Full record

ArticleFrontiers in pediatrics2021

Advantages of Widefield Optical Coherence Tomography in the Diagnosis of Retinopathy of Prematurity.

Thanh-Tin P Nguyen, Shuibin Ni, Shanjida Khan, Xiang Wei, Susan Ostmo, Michael F Chiang, Yali Jia, David Huang, Yifan Jian, J Peter Campbell

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Panretinal Optical Coherence Tomography.IEEE transactions on medical imaging · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Optical coherence tomography imaging of the peripheral retina.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Thanh-Tin P NguyenSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Shuibin NiSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Shanjida KhanSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Xiang WeiSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Susan OstmoSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Michael F ChiangSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Yali JiaSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
David HuangSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Yifan JianSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
J Peter CampbellSchool of Medicine, Casey Eye Institute, Oregon Health and Science University, Portland, OR, United States.
Oregon Health & Science University · USNational Eye Institute · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AAKALU, VINAY · 1985 to 2025
$14.8M
Clinical and Genetic Analysis of Retinopathy of PrematurityR01EY019474 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2010 to 2020
$7.0M
Artificial Intelligence Assisted Panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01HD107494 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yifan Jian · 2021 to 2026
$2.4M
Clinical and genetic analysis of retinopathy of prematurityR01HD107493 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2021 to 2023
$1.8M
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01EY031331 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER, JIAN, YIFAN · 2020 to 2020
$342k
NEI NIH HHS P30 EY001792NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY019474NEI NIH HHS R01 EY031331NICHD NIH HHS R01 HD107493NICHD NIH HHS R01 HD107494
6 · The paper itself

Abstract

Recent advances in portable optical coherence tomography (OCT) and OCT angiography (OCTA) have resulted in wider fields of view (FOV) and shorter capture times, further expanding the potential clinical role of OCT technology in the diagnosis and management of retinopathy of prematurity (ROP). Using a prototype, handheld OCT device, retinal imaging was obtained in non-sedated infants in the neonatal intensive care unit (NICU) as well as sedated infants in the operating room of Oregon Health & Science University (OHSU) Hospital. In this observational study, we provide an overview of potential advantages of OCT-based disease assessment in ROP. We observed that next-generation OCT imaging (a) may be sufficient for objective diagnosis and zone/stage/plus disease categorization, (b) allows for minimally-invasive longitudinal monitoring of disease progression and post-treatment course, (c) provides three-dimensional mapping of the vitreoretinal interface, and (d) with OCTA, enables dye-free visualization of normal and pathologic vascular development.

Indexed as

handheld optical coherence tomographyoptical coherence tomographyoptical coherence tomography with angiographypediatric retinaretinopathy of prematurity

Identifiers

PMID35118032
PMCPMC8806029
OpenAlexW4206697734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.